IT for cell and gene therapies
The vision for digital capabilities for cell and gene therapy is targeted to educate IT professionals in the distinctives of cell and gene therapies, so that they are productive faster and the solutions they create have better foundations, support more products, and are more maintainable.
CGT actors and process maps: Who does what in the supply of different cell and gene therapies describes how the required digital capabilities vary according to the type of cell and gene therapy platform
CGT personas and user stories: What people need the systems to do to support the supply of cell and gene therapies provides a toolkit to support analysis and system design: not just what is needed, but why.
The goal of the program’s ongoing work is to provide consistent approaches with reusable methodologies or frameworks that will help speed up the development of IT architecture to support new modalities.
All of this will accelerate industry alignment and make partnership easier, there’ll be fewer dead-end, unmaintainable, unscalable solutions; more equipment integration and informatics alignment, and better IT foundations to support the future range of CGT products. Ultimately there’ll be fewer deviations and improved patient outcomes.